462
Participants
Start Date
May 31, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
April 30, 2009
imiquimod
5% topical cream dispensed in individual 0.25 g sachets applied twice a week for 16 weeks
Aldara™
5% topical cream dispensed in individual 0.25 g sachets applied twice a week for 16 weeks
Vehicle Cream
Topical cream vehicle matching Generic imiquimod dispensed in individual 0.25 g sachets applied twice a week for 16 weeks
Mt. Sinai School of Medicine, New York
Derm Research Center of New York, Inc., Stony Brook
MedaPhase, Inc., Newnan
FXM Research Corp., Miami
Tennessee Clinical Research Center, Nashville
Dermatology Associates of Knoxville, P.C., Knoxville
University Dermatology Consultants, Inc., Cincinnati
Deaconess Clinic, Inc., Evansville
Minnesota Clinical Study Center, Fridley
Burke Pharmaceutical Research, Hot Springs
Suzanne Bruce & Associates, P.A., Houston
Dermatology Clinical Research Center of San Antonio, San Antonio
DermResearch, Inc., Austin
Cherry Creek Research, Inc., Denver
Dermatology Research Center, Inc., Salt Lake City
Skin Surgery Medical Group, Inc., San Diego
Associates in Research, Inc., Fresno
Oregon Medical Research Center, P.C., Portland
Premier Clinical Research, Spokane
Rhode Island Hospital, Dermatopharmacology Division, Providence
Lead Sponsor
Actavis Inc.
INDUSTRY